# Crick-UCLH-Legacy-AZ-VOCs-2021-06
Data and analysis scripts for Wall, Wu, Harvey _et al._, _Lancet_, 2021.

"AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC"

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01462-8/fulltext

and incorporating data from Wall, Wu, _et al._, _Lancet_, 2021.

"Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination"

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01290-3/fulltext

Please cite both:

Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Adams L, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DL. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021 Jul 17;398(10296):207-209. doi: 10.1016/S0140-6736(21)01462-8. Epub 2021 Jun 28. PMID: 34197809; PMCID: PMC8238446.

AND 

Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Nicod J, Goldstone R, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DLV. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 Jun 19;397(10292):2331-2333. doi: 10.1016/S0140-6736(21)01290-3. Epub 2021 Jun 3. PMID: 34090624; PMCID: PMC8175044.

Available in this repository:
 * Crick_Legacy_2021-24-05_B-1-617-2_PUBLIC.Rda
 * Crick_Legacy_2021-12-06_B-1-617-2_AZ_PUBLIC.Rda
 * Crick_Legacy_AZPfizer_2021-12-06_B-1-617-2_GeneratePlots.R

_Note that the barcode/participant IDs between the Pfizer and AZ datasets overlap due to anonymisation (i.e. don't join on barcodes/IDs without appending an identifier as to which dataset they came from)._
